ATE332970T1 - Verfahren und zusammensetzungen zur hemmung von neoplastischem zellwachstums - Google Patents

Verfahren und zusammensetzungen zur hemmung von neoplastischem zellwachstums

Info

Publication number
ATE332970T1
ATE332970T1 AT99970398T AT99970398T ATE332970T1 AT E332970 T1 ATE332970 T1 AT E332970T1 AT 99970398 T AT99970398 T AT 99970398T AT 99970398 T AT99970398 T AT 99970398T AT E332970 T1 ATE332970 T1 AT E332970T1
Authority
AT
Austria
Prior art keywords
methods
compositions
cell growth
neoplastic cell
inhibiting neoplastic
Prior art date
Application number
AT99970398T
Other languages
English (en)
Inventor
Avi Ashkenazi
Audrey Goddard
Austin L Gurney
Robert D Klein
Mary Napier
William I Wood
Jean Yuan
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of ATE332970T1 publication Critical patent/ATE332970T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT99970398T 1998-10-13 1999-10-05 Verfahren und zusammensetzungen zur hemmung von neoplastischem zellwachstums ATE332970T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10408098P 1998-10-13 1998-10-13

Publications (1)

Publication Number Publication Date
ATE332970T1 true ATE332970T1 (de) 2006-08-15

Family

ID=22298575

Family Applications (2)

Application Number Title Priority Date Filing Date
AT99970398T ATE332970T1 (de) 1998-10-13 1999-10-05 Verfahren und zusammensetzungen zur hemmung von neoplastischem zellwachstums
AT04025897T ATE363536T1 (de) 1998-10-13 1999-10-05 Verfahren und zusammenstzung zur hemmung des wachtums von neoplastischen zellen

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT04025897T ATE363536T1 (de) 1998-10-13 1999-10-05 Verfahren und zusammenstzung zur hemmung des wachtums von neoplastischen zellen

Country Status (15)

Country Link
EP (1) EP1121439B1 (de)
JP (1) JP2002527452A (de)
KR (2) KR100448427B1 (de)
AT (2) ATE332970T1 (de)
AU (1) AU758462B2 (de)
CA (1) CA2344465A1 (de)
DE (2) DE69932342T2 (de)
DK (2) DK1121439T3 (de)
ES (2) ES2290606T3 (de)
IL (3) IL142088A0 (de)
MX (1) MXPA01003636A (de)
NZ (1) NZ510584A (de)
PT (2) PT1121439E (de)
WO (1) WO2000021996A2 (de)
ZA (1) ZA200102380B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7169906B2 (en) 1997-09-17 2007-01-30 Genentech, Inc. PRO211 polypeptides
US6974689B1 (en) 1997-09-18 2005-12-13 Genentech, Inc. Nucleic acid encoding PRO211 polypeptides
US7049403B2 (en) * 2000-04-21 2006-05-23 Takeda Pharmaceutical Company Limited Insulin/IGF/relaxin family polypeptides and DNAS thereof
BRPI0821600A2 (pt) * 2007-12-28 2015-06-23 Bioinvent Int Ab Composição farmacêutica, artigo de fabricação, kit de partes, método de combater aterosclerose, ou uma doença cardiovascular associada à aterosclerose, e, uso de um anticorpo

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ226799A (en) * 1987-11-06 1991-08-27 Oncogen Breast cancer inhibitory factor and method for inhibiting proliferation of neoplastic cells and compositions therefor
US5814307A (en) * 1989-04-10 1998-09-29 Bristol-Myers Squibb Company Method for regulating cell growth, leukocyte differentiation and tumor cell growth using Oncostatin M to stimulate synthesis of IL-6
US5416192A (en) * 1990-04-03 1995-05-16 Bristol-Myers Squibb Company Epithelins: novel cysteine-rich growth modulating proteins
AU9312198A (en) * 1997-09-17 1999-04-05 Genentech Inc. Genes amplified in tumours, antibodies against the proteins encoded thereby, andtheir use in diagnosis and treatment of cancer
JP2001516580A (ja) * 1997-09-17 2001-10-02 ジェネンテック・インコーポレーテッド 分泌性の、および膜貫通性のポリぺプチド、およびそれをコードする核酸

Also Published As

Publication number Publication date
KR100448426B1 (ko) 2004-09-13
KR100448427B1 (ko) 2004-09-16
DK1121439T3 (da) 2006-11-13
DK1518930T3 (da) 2007-10-01
IL142088A (en) 2008-11-26
KR20010085915A (ko) 2001-09-07
ES2268901T3 (es) 2007-03-16
EP1121439B1 (de) 2006-07-12
AU1200500A (en) 2000-05-01
KR20030096387A (ko) 2003-12-24
CA2344465A1 (en) 2000-04-20
ES2290606T3 (es) 2008-02-16
JP2002527452A (ja) 2002-08-27
DE69936234D1 (de) 2007-07-12
WO2000021996A2 (en) 2000-04-20
IL142088A0 (en) 2002-03-10
PT1518930E (pt) 2007-09-04
WO2000021996A3 (en) 2000-11-09
DE69936234T2 (de) 2008-03-06
DE69932342D1 (de) 2006-08-24
NZ510584A (en) 2003-04-29
MXPA01003636A (es) 2003-10-14
AU758462B2 (en) 2003-03-20
EP1121439A2 (de) 2001-08-08
PT1121439E (pt) 2006-12-29
ZA200102380B (en) 2002-03-22
ATE363536T1 (de) 2007-06-15
IL189502A0 (en) 2008-06-05
DE69932342T2 (de) 2007-07-12

Similar Documents

Publication Publication Date Title
ATE269295T1 (de) Btk inhibitoren und verfahren zur identifizierung und verwendung
WO2003103581A3 (en) COMPOSITIONS AND METHODS FOR LIVER GROWTH AND PROTECTION
DE602004015811D1 (de) Verfahren zur inhibierung der proliferation von tumorzellen, bei dem platinkomplexe eingesetzt werden
ATE294595T1 (de) Radioaktive zusammensetzungen zur behandlung von prostatatumoren
DE60015070D1 (de) Verwendung von antikonvulsiven derivaten zur behandlung der cluster headache
DE69936890D1 (de) Vorrichtung zur Behandlung von Ischämie
DE60034871D1 (de) Verfahren und zusammensetzungen zur prevention oder behandlung von krebs und von krebs assoziertem knochenverlust
WO2001075178A3 (en) Methods for identifying peptide aptamers capable of altering a cell phenotype
IS2631B (is) Aðferðir þar sem integrín-mótlyf eru notuð til að meðhöndla margföld mergæxli og uppsog í bein af völdum mergæxla
DE60021381D1 (de) Chinonverbindungen zur behandlung von krankheiten
DE69915310D1 (de) Methoden zur behandlung der salzabhängigen hypertonie
DE69941821D1 (de) Fluorenthaltende zusammensetzung zur behandlung von oberflächen
ATE232191T1 (de) Verfahren und zusammensetzung zur inhibierung der polymerisierung von ethylenisch ungesättigten kohlenwasserstoffen
ATE196083T1 (de) Verwendung von ferrioxamin-b zur behandlung septischen schocks
DE69828779D1 (de) Radionukleiide assoziierte nukleotid-polyphosphate zur bilddarstellung von tumoren
IL189502A0 (en) Methods and compositions for inhibiting neoplastic cell growth
ATE423129T1 (de) Inhibitoren von lyn-verbundener signaltransduktion (last) und deren verwendung zur behandlung von prostatakrebs
EA200301126A1 (ru) Противоопухолевая композиция, содержащая толуолсульфонамид, и способ ее применения
DE69915690D1 (de) Antikonvulsive derivate zur behandlung von posttraumatischen stresserkrankungen
ATE288498T1 (de) Methoden zur inhibierung von helicobacter pylori
MXPA05001690A (es) Estrategia de deteccion para farmacos anticancer.
ATE405577T1 (de) Lactam dipeptid und dessen verwendung zur inhibierung der beta-amyloid peptid frisetzung
WO2000012754A8 (en) Method for identifying substances for the treatment of c-jun-mediated disorders
ATE338768T1 (de) Muc-1 derivate und deren verwendung zur behandlung von krebsassoziierter muc-1 mucin induzierter immunosuppression
EP1518930A3 (de) Verfahren und Zusammensetzung zur Hemmung des Wachsdums von neoplastischen Zellen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1121439

Country of ref document: EP